2m 2m 2m 2m 2m 2m 2m
VAXCYTE (PCVX)
NASDAQ
$51.95-$0.16 (-0.32%)
Price as of Jun 23, 2026 4:10 PM EDT- $7.5BMarket Cap
- 56.72%1-Year Change
- BiotechnologyIndustry
VAXCYTE (PCVX)
$51.95-$0.16 (-0.32%)
PCVX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $52.11 | ||
Change | +$0.67 (+1.30%) | ||
Open | $51.71 | ||
High | $52.95 | ||
Low | $50.82 | ||
Previous Close | $51.44 | ||
Volume | 1,473,743 | ||
30-Day Average Volume | 1,436,976 | ||
1-Week Change | 5.15% | ||
1-Month Change | 10.17% | ||
1-Year Change | 56.72% | ||
3-Year Change | -3.62% | ||
5-Year Change | 144.19% | ||
Fundamentals | |||
Shares Outstanding | 144.4M | ||
Total Assets | $3.3B | ||
Market Cap | $7.5B | ||
Enterprise Value | $7.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$320.6M | ||
Free Cash Flow | -$282.7M | ||
EBIT | -$320.6M | ||
EBITDA | -$317.7M | ||
Net Working Capital | $1.6B | ||
EPS | -$2.30 | ||
Enterprise Value/EBITDA | -23 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -23 | ||
PEG | 1 | ||
Price/Free Cash Flow | -27 | ||
Price/Operating Cash Flow | -27 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue